Back to Atlas
APotentially durableStandard research/education caution
CMP-0151
Research/Regional
Vilon
Immune / Longevity
Immune and geroprotective positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Short peptide bioregulator
- Primary mechanism
- Peptide bioregulation
- Primary market use
- Longevity / immune
Pharmacology
- Molecular weight (Da)
- ~275
- Oral bioavailability
- Unknown
- Half-life
- 1 to 2 hours
- Route tags
- SubQ; IM
- Evidence level
- Limited human/Regional
- Clinical status
- Research/Regional
- Value-for-money score
- 4 / 10
Reported protocol signal
Common reported Cytogen injectable protocol: 1–10 mg daily for 10–20 days SQ/IM; popular simplified protocol 2 mg daily for 20–30 days, 1 month on / 2 months off, 2–3×/year.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Evidence base limited